We are live on ! Find out more
TSHA icon

Taysha Gene Therapies
TSHA

48 hedge funds and large institutions have $388M invested in Taysha Gene Therapies in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

420% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 5

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

8% more capital invested

Capital invested by funds: $358M → $388M (+$29.7M)

4% more funds holding

Funds holding: 46 → 48 (+2)

1.54% more ownership

Funds ownership: 46.77% → 48.31% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
26
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$16.3M
2
NCM
Nantahala Capital Management
Connecticut
+$9.11M
3
TCM
TimesSquare Capital Management
New York
+$6.6M
4
State Street
State Street
Massachusetts
+$4.53M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.32M

Top Sellers

Rank Fund Capital Flow
1
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
-$18.2M
2
CC
Casdin Capital
New York
-$16.7M
3
PA
Perceptive Advisors
New York
-$3.46M
4
VA
VR Adviser
New York
-$2.45M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$2.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$651K +$405K +17,584 +134%
Millennium Management
27
Millennium Management
New York
$639K +$208K +9,040 +43%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$611K +$664K +28,800 New
Bank of America
29
Bank of America
North Carolina
$517K +$220K +9,524 +64%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$406K +$239K +10,374 +118%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$396K +$430K +18,671 New
DC
32
Davenport & Co
Virginia
$292K -$148K -6,400 -32%
Deutsche Bank
33
Deutsche Bank
Germany
$286K +$177K +7,670 +131%
CS
34
Credit Suisse
Switzerland
$283K +$309K +13,389 New
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$275K +$299K +12,965 New
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$243K +$264K +11,448 New
MIM
37
MetLife Investment Management
New Jersey
$202K +$219K +9,509 New
VEA
38
Virtus ETF Advisers
New York
$184K +$200K +8,697 New
UBS Group
39
UBS Group
Switzerland
$112K -$713K -30,911 -85%
Legal & General Group
40
Legal & General Group
United Kingdom
$80K +$65.3K +2,835 +310%
AIP
41
Ameritas Investment Partners
Nebraska
$37K +$23.5K +1,018 +140%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$32K +$15.1K +657 +75%
Citigroup
43
Citigroup
New York
$29K +$18.3K +795 +138%
CAPTRUST Financial Advisors
44
CAPTRUST Financial Advisors
North Carolina
$22K +$1.38K +60 +6%
TRCT
45
Tower Research Capital (TRC)
New York
$21K +$8.07K +350 +56%
RE
46
RBC Europe
United Kingdom
$5.3K – – –
Osaic Holdings
47
Osaic Holdings
Arizona
$5K – – –
AIG
48
American International Group
New York
$264 +$171K +7,415 +147%
CC
49
Casdin Capital
New York
– -$16.7M -820,440 Closed
VA
50
VR Adviser
New York
– -$2.45M -120,649 Closed
1
2
3

TSHA Hedge Fund Activity: Q2 2021 in Review

48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Taysha Gene Therapies (TSHA) for Q2 2021, worth a combined $388M — up 8.3% from $358M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TSHA positions and 8 closed out — a net gain of 2 holders — while 26 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $16.3M. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $18.2M.

  • 48 institutional investors held Taysha Gene Therapies (TSHA) as of Q2 2021, up from 46 in Q1 2021.
  • Funds reported $388M of Taysha Gene Therapies stock for Q2 2021, up 8.3% quarter-over-quarter.
  • 10 funds opened new Taysha Gene Therapies positions in Q2 2021 and 8 closed out, a net change of +2 holders.
  • The largest Taysha Gene Therapies buyer in Q2 2021 was BlackRock, an estimated $16.3M added.
  • The largest Taysha Gene Therapies seller in Q2 2021 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2021.